@article{oai:repo.qst.go.jp:00084730,
 author = {Komatsu, Shuichiro and Masahiko, Okamoto and Shintaro, Shiba and Kaminuma, Takuya and Okazaki, Shohei and Hiroki, Kiyohara and Yanagawa , Takashi and Takashi, Nakano and Tatsuya, Ohno and Masahiko, Okamoto and Shintaro, Shiba and Kaminuma, Takuya and Hiroki, Kiyohara and Takashi, Nakano and Tatsuya, Ohno},
 issue = {11},
 journal = {Cancers},
 month = {Sep},
 note = {Carbon-ion radiotherapy (CIRT) represents a definitive treatment for inoperable bone and soft tissue sarcoma (BSTS). This prospective study analyzed 61 patients with inoperable BSTS who were treated with CIRT to evaluate QOL, functional outcomes, and predictive factors in patients with inoperable BSTS treated with definitive CIRT. The Musculoskeletal Tumor Society (MSTS) scoring system and the Short Form (SF)-8 questionnaire were completed before and at 1, 3, 6, 12, and 24 months after CIRT. The median follow-up period was 38 months. The main site of primary disease was the pelvis (70.5%), and the most common pathologic diagnosis was chordoma (45.9%). The 3-year overall survival and local control rates were 87.8% and 83.8%, respectively. The MSTS score and physical component score (PCS) of SF-8 did not change significantly between the baseline and subsequent values. The mental component score of SF-8 significantly improved after CIRT. Multivariate analysis showed that the normalized MSTS and normalized PCS of SF-8 at the final follow-up were significantly affected by performance status at diagnosis and sex. CIRT showed clinical efficacy, preserving the physical component of QOL and functional outcomes and improving the mental component of QOL, suggesting its potential value for the treatment of patients with inoperable BSTS},
 title = {Prospective Evaluation of Quality of Life and Functional Outcomes after Carbon Ion Radiotherapy for Inoperable Bone and Soft Tissue Sarcomas},
 volume = {13},
 year = {2021}
}